These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16352945)

  • 1. [A paclitaxel-resistant case of recurrent breast cancer responded to combination therapy of capecitabine and trastuzumab].
    Marutaka M; Suguri T; Miyake M; Yoshimura K
    Gan To Kagaku Ryoho; 2005 Dec; 32(13):2137-9. PubMed ID: 16352945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Two cases of recurrent breast cancer with regional lymph node metastases showing a complete response to trastuzumab and paclitaxel treatment].
    Ohsako T; Inoue K; Nagamoto N; Yoshida Y; Nakahara O
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1301-3. PubMed ID: 16969029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Case report of advanced breast cancer responding to capecitabine and trastuzumab combination therapy].
    Yoshidome K; Imabun S; Nakahara M; Hiraoka K; Yamagami Y; Tsujimoto M; Nakao K
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1453-6. PubMed ID: 17033236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified resistance to chemotherapy and trastuzumab by bevacizumab in locally recurrent breast cancer.
    Farhat MH; El-Saghir NS; Shamseddine AI
    Breast; 2009 Feb; 18(1):66-8. PubMed ID: 19013064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lapatinib plus capecitabine resolved human epidermal growth factor receptor 2-positive brain metastases.
    Glück S; Castrellon A
    Am J Ther; 2009; 16(6):585-90. PubMed ID: 19287304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effective combination chemotherapy using weekly trastuzumab and paclitaxel in the treatment of a recurrent breast cancer patient with liver metastases].
    Tohnosu N; Kobayashi Y; Saito T; Shimizu T; Natsume T; Tanaka H; Maruyama T; Watanabe Y
    Gan To Kagaku Ryoho; 2003 Jul; 30(7):989-92. PubMed ID: 12894716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential role of chemo-radiation with oral capecitabine in a breast cancer patient with central nervous system relapse.
    Hikino H; Yamada T; Johbara K; Obayashi N; Ozaki N
    Breast; 2006 Feb; 15(1):97-9. PubMed ID: 16005228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of elderly metastatic breast cancer with a complete response to treatment with capecitabine and cyclophosphamide].
    Iida S; Furukawa K; Yokoyama T; Yanagihara K; Iwasaki R; Noguchi T; Tsuchiya S; Sugisaki Y; Naito Z; Tajiri T
    Gan To Kagaku Ryoho; 2007 Oct; 34(10):1697-700. PubMed ID: 17940394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metastatic breast cancer treated with trastuzumab and paclitaxel--a case report with clinically complete response].
    Yoshida T; Horiguchi J; Koibuchi Y; Kanoh T; Iijima K; Yoshida M; Kikuchi M; Takata D; Oyama T; Iino Y; Morishita Y
    Gan To Kagaku Ryoho; 2004 Jun; 31(6):907-10. PubMed ID: 15222110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant capecitabine, docetaxel, cyclophosphamide, and epirubicin for early breast cancer: final analysis of the randomized FinXX trial.
    Joensuu H; Kellokumpu-Lehtinen PL; Huovinen R; Jukkola-Vuorinen A; Tanner M; Kokko R; Ahlgren J; Auvinen P; Paija O; Helle L; Villman K; Nyandoto P; Nilsson G; Pajunen M; Asola R; Poikonen P; Leinonen M; Kataja V; Bono P; Lindman H
    J Clin Oncol; 2012 Jan; 30(1):11-8. PubMed ID: 22105826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of trastuzumab every 3 weeks combined with cytotoxic chemotherapy in patients with HER2-positive recurrent breast cancer: findings from a case series.
    Ardavanis A; Tryfonopoulos D; Orfanos G; Karamouzis M; Scorilas A; Alexopoulos A; Rigatos G
    Onkologie; 2005 Nov; 28(11):558-64. PubMed ID: 16249641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bi-weekly nab-paclitaxel and trastuzumab therapy effective against recurrent breast cancer with multiple lung metastases in elderly patient who had previously undergone two chemotherapeutic regimens for treatment of metastatic disease-a case Report].
    Sakurai T; Jinta E; Suzuma T; Yoshimura G; Umemura T; Sakurai T
    Gan To Kagaku Ryoho; 2012 Nov; 39(11):1703-6. PubMed ID: 23152023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II study of trastuzumab and capecitabine for patients with HER2-overexpressing metastatic breast cancer: Japan Breast Cancer Research Network (JBCRN) 00 Trial.
    Yamamoto D; Iwase S; Kitamura K; Odagiri H; Yamamoto C; Nagumo Y
    Cancer Chemother Pharmacol; 2008 Mar; 61(3):509-14. PubMed ID: 17516068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination versus sequential single-agent therapy in metastatic breast cancer.
    Miles D; von Minckwitz G; Seidman AD
    Oncologist; 2002; 7 Suppl 6():13-9. PubMed ID: 12454315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of capecitabine plus trastuzumab in human epidermal growth factor receptor 2 overexpressing metastatic breast cancer pretreated with anthracyclines or taxanes.
    Schaller G; Fuchs I; Gonsch T; Weber J; Kleine-Tebbe A; Klare P; Hindenburg HJ; Lakner V; Hinke A; Bangemann N
    J Clin Oncol; 2007 Aug; 25(22):3246-50. PubMed ID: 17577021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete remission of recurrent breast cancer with multiple liver metastases after oral capecitabine and injected trastuzumab.
    Morohashi S; Odagiri H; Morohashi H; Kimura Y; Sasaki M
    Breast Cancer; 2007; 14(3):297-301. PubMed ID: 17690508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A patient with advanced recurrent breast cancer who firmly resisted hair loss and was then treated by combination therapy with high-dose toremifene and capecitabine].
    Akahane T; Chiba T; Yano H; Hashimoto Y
    Gan To Kagaku Ryoho; 2007 Mar; 34(3):435-8. PubMed ID: 17353638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of leptomeningeal metastases from breast cancer using the combination of trastuzumab and capecitabine: a case report.
    Shigekawa T; Takeuchi H; Misumi M; Matsuura K; Sano H; Fujiuchi N; Okubo K; Osaki A; Aogi K; Saeki T
    Breast Cancer; 2009; 16(1):88-92. PubMed ID: 18478315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancer.
    Gajria D; Gonzalez J; Feigin K; Patil S; Chen C; Theodoulou M; Drullinsky P; D'Andrea G; Lake D; Norton L; Hudis CA; Traina TA
    Breast Cancer Res Treat; 2012 Jan; 131(1):111-6. PubMed ID: 21898114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of therapeutic regimens for taxane-resistant recurrent/metastatic breast cancer].
    Kan N; Yoshikawa K; Nio Y; Iguchi C; Kodama H
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1047-52. PubMed ID: 17637540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.